AnswersNow Lands $40M to Expand AI-Driven Autism Therapy Model

RICHMOND, Va. – January 21, 2026 – AnswersNow, a virtual autism therapy provider, today announced the closing of a $40 million Series B funding round to scale its technology-driven approach that promises to slash therapy hours and costs while improving outcomes for families. The round was led by HealthQuest Capital, a firm focused on transformative healthcare companies, with continued participation from existing investors Left Lane Capital and Owl Ventures.

The new capital injection will be used to aggressively expand the company's platform, which combines expert clinicians with an artificial intelligence engine to deliver personalized Applied Behavioral Analysis (ABA) therapy. AnswersNow plans to double its clinical staff, add to its leadership team, and roll out new services to meet the surging demand for accessible autism support. This funding signals strong investor confidence in a model that directly confronts the accessibility, cost, and efficiency crises plaguing the autism care landscape.

Confronting a System at its Breaking Point

The need for innovative solutions in autism care has never been more acute. According to 2023 data from the Centers for Disease Control and Prevention (CDC), an estimated 1 in 36 children in the United States is diagnosed with autism spectrum disorder, a significant increase from 1 in 150 at the turn of the century. This rising prevalence has placed immense strain on a healthcare system ill-equipped to handle the demand.

For families, a diagnosis is often the beginning of a frustrating journey marked by long waitlists and prohibitive costs. Research shows that families can wait over five months, and in some cases more than a year, just for an initial appointment. During this critical developmental period, delays can lead to worsening behaviors and missed opportunities for early intervention. Traditional in-person ABA therapy, while considered effective, typically requires an intensive 30 to 40 hours per week. Without robust insurance, the annual cost can soar to over $200,000, creating an insurmountable financial barrier for many.

"The autism support system in America is broken, leaving families to wait months or longer for services at untenable costs for insurers," said HealthQuest Capital Partner Sam Brasch. Henry Toole, a partner at returning investor Left Lane Capital, echoed this sentiment, noting that the "widening gap in support services means most families are forced to wait months or longer for a first appointment." AnswersNow aims to solve this by connecting families to its high-level clinicians within five days, effectively eliminating the waitlist.

A New Model: AI, Experts, and Efficiency

At the heart of AnswersNow's strategy is a radical reimagining of how ABA therapy is delivered. The company has moved away from the high-hour, in-person model and instead built a virtual platform that delivers what it claims are superior results in just four to five hours per week—an 85% reduction in time commitment.

The model has two core components. First, it relies exclusively on Board-Certified Behavioral Analysts (BCBAs), who hold Master's or PhD degrees, to deliver all therapy and caregiver training. This contrasts with traditional models that often rely heavily on less-credentialed Registered Behavior Technicians (RBTs) for direct service delivery. Second, it leverages a proprietary AI platform to create highly personalized learning modules for each child. The AI analyzes a child's unique interests and affinities—be it dinosaurs, trains, or a specific cartoon character—and adapts therapy materials accordingly.

"The data shows that by exclusively using Master's- and PhD-level BCBAs for targeted parent training, in combination with our AI-enabled, focused therapy for children, we can achieve equal or better outcomes at a fraction of the time and cost," said AnswersNow CEO Jeff Beck.

This focus on personalization is key to the model's efficiency. According to the company, when therapy materials align with what naturally motivates a child, skill acquisition happens faster and generalizes more effectively to real-world situations. This approach also empowers parents, training them to become effective agents of therapy in everyday moments, thereby multiplying the impact of each clinical hour.

The Economic Imperative and Investor Confidence

The efficiency of the AnswersNow model carries profound financial implications. By drastically reducing the required therapy hours, the company reports it can cut total autism care costs for payors—including commercial insurers and Medicaid plans—by up to 75%. In an environment where healthcare providers are under constant pressure to deliver value-based care, this figure has captured the attention of both investors and insurers.

The $40 million investment from HealthQuest Capital, Left Lane Capital, and Owl Ventures is a clear bet on the financial sustainability and scalability of this approach. For payors who have long struggled with the high and often unpredictable costs of traditional ABA, a model that promises both clinical efficacy and cost control is a powerful proposition. AnswersNow is already an in-network provider for major commercial and Medicaid plans in multiple states, a critical step for ensuring broad access.

"AnswersNow's virtual therapy model aims to deliver results in less time and with lower costs than traditional therapy," Brasch stated, explaining HealthQuest's lead investment. "We're excited to join them in helping families and creating a more sustainable model for our healthcare system." This focus on a sustainable economic model, paired with a high-touch clinical approach, appears to be the formula that has convinced investors to double down on the company's growth.

Proven Impact and the Path Forward

While the model's efficiency is compelling, its success ultimately hinges on delivering tangible results for families. On this front, AnswersNow reports impressive metrics. In 2025 alone, the company facilitated nearly 100,000 hours of virtual therapy and caregiver training. Within six months on the platform, 96% of families report meaningful improvements in their child's behavior and communication skills. This user satisfaction is further reflected in a Net Promoter Score (NPS) of 83, a score that indicates exceptional customer loyalty and is well above industry averages.

To further cement its clinical claims, AnswersNow announced it will publish first-of-its-kind research in early 2026. This study is expected to formally document the platform's superior outcomes and efficiency, providing the data-driven validation that payors and the broader medical community require.

With the new funding, the company is poised for rapid expansion. The plan to double its clinical staff of BCBAs is a direct response to the overwhelming demand and a commitment to maintaining its no-waitlist promise. By investing further in its AI capabilities and service offerings, AnswersNow is not just scaling a business; it is aiming to fundamentally reshape the standards of autism care, making it more accessible, affordable, and effective for families everywhere.